MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition which occurs within 48 hours following a trauma. Currently ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P’s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device.
MY01. The simple solution to a dangerous problem.
Engineered by NXTSENS
MY01. The simple solution to a dangerous problem.
Engineered by NXTSENS
Location: Canada, Montreal (06), Montreal
Employees: 11-50
Total raised: $12.5M
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | CTS | ctssante.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.04.2023 | - | $12.5M | - |
Mentions in press and media 8
| Date | Title | Description |
| 04.09.2025 | MedTech M&A Surges in 2025: Why Startups Are Now Ripe for Acquisition | After a few mixed years in medical technology (MedTech) mergers and acquisition (M&A) activity, 2025 is shaping up to be a landmark year, particularly among cash-rich medical device strategics. In Q1 2025, there were 57 MedTech M&A ... |
| 18.04.2023 | 22 MedTech Innovator all-stars will pitch at DeviceTalks Boston | Nearly two dozen MedTech Innovator portfolio startups will pitch their technology to medtech industry innovators, executives and engineers at DeviceTalks Boston on May 10-11. The MedTech Innovator accelerator program picked the 22 all-stars... |
| 12.04.2023 | MY01 raises $12.5 million CAD for microsensors that aid in physician diagnostics | - |
| 11.04.2023 | MY01 Raises $12.5M in Funding | MY01, a Montreal, Canada-based medical technology company, raised $12.5M in funding. The round was led by Investissement Quebec, with participation from Desjardins Capital and Fondaction. The company intends to use the funds to expand comme... |
| 06.05.2021 | MY01 Inc. receives FDA Clearance for the MY01 Continuous Compartment Pressure Monitor as an aid in diagnosis of Compartment Syndrome | |
| 12.06.2019 | Eight Canadian healthtech companies part of initial MedTeq fund investments | Eight Canadian healthtech companies have received investments from Montreal-based MedTeq, a pan-Canadian health-technology investment organization, as part of its first round of venture investments. The eight healthtech companies raised a t... |
| - | MY01 Raises $12.5 Million To Develop Microsensors For Aiding Physicians | MY01 – a medical technology company that uses microsensors to aid physicians in diagnosing compartment syndrome – announced it has raised a $12.5 million Series A funding round. The funding round was led by Investissement Quebec with partic... |
| - | MY01 | “MY01 – Timely Sensing.” |